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doi:10.1Objectives: Surgical repair of the aortic arch remains technically challenging and is associated with considerable
morbidity and mortality. Cerebral oximetry is a noninvasive technology that can monitor the regional oxygen sat-
uration of the frontal cortex. We hypothesized that magnitude and duration of decreased intraoperative regional
oxygen saturation was associated with postoperative organ dysfunction. Additionally, we sought to identify
regional oxygen saturation threshold values that are predictive of organ dysfunction.
Methods: The intraoperative regional oxygen saturation values of 30 patients undergoing aortic arch surgery
were recorded and analyzed. Postoperative complications were categorized as ‘‘major’’ and ‘‘minor.’’ Severe ad-
verse outcome, extubation time, intensive care unit length of stay, and hospital length of stay data were collected
and compared with the integrals of regional oxygen saturation and time (area under the threshold) spent beneath
predetermined absolute threshold limits.
Results: Twenty subjects underwent hemiarch replacement, and 10 subjects received total aortic arch replace-
ments. There were 30 major and 29 minor complications identified. Sixteen (53.3%) patients had at least 1 major
complication. Logistic regression showed statistically significant associations between area under the threshold
and severe adverse outcome incidence for regional oxygen saturation thresholds of 60% (P ¼ .038) and 65%
(P ¼ .025). Patients who spent more than 30 minutes under the absolute threshold of 60% had an extended
hospital stay of 4 days leading to an additional cost of $8300.00.
Conclusions: Our findings lend evidence to support the association of decreased perioperative cerebral oxygen-
ation values with poor outcomes after aortic arch surgery. (J Thorac Cardiovasc Surg 2011;141:815-21)E
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SSurgical repair of the aortic arch remains technically chal-
lenging and is associated with considerable morbidity and
mortality. Prolonged cardiopulmonary bypass (CPB) times,
embolic risk, and interruption of brain blood flow are inte-
gral to these procedures. Consequently, neurologic and neu-
ropsychologic sequelae occur more frequently with aortic
arch surgery than with coronary and valvular cardiac sur-
gery; stroke rates have been reported in the range of 6%
to 13%,1 with neuropsychologic impairment being even
more frequent.2
Near-infrared spectroscopy technology has been used to
monitor cerebral oxygenation noninvasively, and these
data may be predictive of adverse neurologic outcomes.
Murkin and colleagues3 monitored near-infrared spectros-
copy and targeted therapy to optimize cerebral tissue oxygen
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The Journal of Thoracic and Cabypass grafting. They found that a composite measure of or-
gan dysfunction was substantially improved in the treatment
group where goal-directed therapy aimed to maintain the
SctO2 values within 25% of the preinduction baseline.
More recently developed near-infrared spectroscopy tech-
nology using a 4-wavelength interrogation of brain tissue
has been validated as a monitor of absolute SctO2.
4 A poten-
tial advantage of absolute brain tissue oxygenation is that
threshold values may be more strongly associated with ad-
verse outcomes than trends. We hypothesized that magni-
tude and duration of decreased intraoperative SctO2 was
associated with postoperative organ dysfunction after aortic
arch surgery. Additionally, we sought to identify SctO2
threshold values that are predictive of organ dysfunction.METHODS
With institutional review board approval and informed consent, 31 pa-
tients undergoing elective thoracic aortic surgery with deep hypothermic
circulatory arrest (DHCA), with or without anterograde selective cerebral
perfusion (SCP), were monitored intraoperatively using the FORE-
SIGHT cerebral oximeter (CAS Medical Systems, Branford, Conn) at our
institution from 2005 to 2008 (Figure 1).
After the induction of general anesthesia, 2 sensors were placed on the
subjects’ foreheads bilaterally for continuous monitoring of SctO2. SctO2
values were recorded every 2 seconds starting after induction of anesthesia
until the end of surgery. SctO2 minutes and the area under the threshold
(AUT) spent beneath the absolute threshold limits of 50%, 55%, 60%,
and 65% were computed for both left and right sensors during the entirerdiovascular Surgery c Volume 141, Number 3 815
Abbreviations and Acronyms
AUT ¼ area under the threshold
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
ICU ¼ intensive care unit
LOS ¼ length of stay
SAO ¼ severe adverse outcome
SCP ¼ selective cerebral perfusion
SctO2 ¼ cerebral tissue oxygen saturation
TUT ¼ time under the threshold




Sintraoperative period. Figure 2 demonstrates the AUT. The AUT was calcu-
lated on the basis of this formula:
AUTðpresentÞ ¼ AUTðpastÞþðSctO2 threshold
 SctO2 valueÞ3 sample rate
Complications were categorized as ‘‘major’’ and ‘‘minor.’’ Major com-
plications were defined as death, stroke with persisting neurologic deficits at
time of discharge, new onset of impaired myocardial function (defined as
decrease of left ventricular ejection fraction>20% from preoperative base-
line), respiratory failure (defined as ventilator dependency>3 days or rein-
tubation), sepsis, delirium, new onset renal failure (defined as requiring
renal replacement therapy after surgery), gastrointestinal complication (is-
chemia or hemorrhage requiring an intervention), and severe volume over-
load (defined as weighing > 20 kg when compared with preoperative
weight). Minor or no complications included new onset of atrial fibrillation,
minor volume overload (defined as 10–20 kg over preoperative weight),
phlebitis, or no complication.
Postoperative complications, extubation time, intensive care unit (ICU)
length of stay (LOS), and hospital LOS data were collected and compared
with SctO2 data and DHCA time.
Anesthesia and Monitoring
After the application of standard American Society of Anesthesiologists
monitors, general anesthesia was induced in all patients with etomidate, fen-
tanyl, and midazolam. Neuromuscular blockade was achieved with vecuro-
nium or cisatracurium before tracheal intubation. A balanced anesthetic
technique was used for maintenance, consisting of isoflurane (0.6%–1.5%
end-tidal concentration), fentanyl, vecuronium or cisatracurium, and mida-
zolam. All patients were mechanically ventilated with an inspired oxygen
fraction of 100% in a pressure-regulated volume-controlled mode so as to
maintain the PaCO2 at 35 to 45 mm Hg. Vital signs and depth of anesthesia
were monitored and controlled in accordance with best clinical practice at
the discretion of the attending anesthesiologist. All patients were transferred
after the end of surgery, still under the influence of general anesthesia, to the
cardiothoracic ICU for further clinical management.
The following monitors were placed: a left radial arterial catheter, a pul-
monary artery catheter inserted via the right internal jugular vein, a 20-
gauge jugular bulb catheter for intermittent sampling of jugular venous
blood, and a urinary bladder catheter with an integrated temperature therm-
istor (to measure core temperature). Transesophageal echocardiography was
performed routinely in all patients.
A glucocorticoid bolus after induction of anesthesia was administered to
all patients according to an institutional protocol (methylprednisone 30 mg/
kg). All patients received either epsilon-aminocaproic acid or aprotinin.
Epsilon-aminocaproic acid was administered as a 150 mg/kg bolus, fol-
lowed by an infusion (15 mg $ kg1 $ h1) for the duration of the case. Apro-
tinin was administered according to the Hammersmith protocol.5816 The Journal of Thoracic and Cardiovascular SurgSubjects remained in the supine position during surgery, allowing for
only positional changes to facilitate surgical exposure. There was no alter-
ation in surgical technique or routine clinical monitoring.
Surgical Technique
All patients received right axillary cannulation as described by Strauch
and associates.6 After sternotomy and dissection of the heart and great ves-
sels, a 2-stage cannula was placed into the right atrium for venous drainage.
Two subsets of patients requiring elective thoracic aortic arch surgery
were included in this study. The first population required replacement of
the entire aortic arch. The technique used is described in detail by Spielvogel
and colleagues.7 In brief, after CPB is commenced, patients are cooled to
a nasopharyngeal temperature of 12C to 15C with alpha-stat management.
Ischemic DHCA is commenced once the aforementioned criteria are ful-
filled. During circulatory arrest, a trifurcated graft is sewn to the head ves-
sels. Once all 3 anastomoses are completed, the graft is deaired and the
proximal end clamped. Via the right axillary artery, antegrade SCP is started
(10 mL/kg ideal body weight per minute) after 15 to 45 minutes of ischemic
DHCA. During SCP a tube graft is used to connect the nondiseased portion
of the ascending aorta with the proximal end of the descending aorta. Sub-
sequently, the trifurcated graft is sewn to the aortic tube graft. After metic-
ulous deairing, total body perfusion is commenced and the patient is
rewarmed.
The other group consisted of patients requiring repair of the ascending
aorta with a beveled suture line at the arch (hemiarch procedure). This tech-
nique is described by Etz and collegues in detail.8 In brief, the CPB tech-
nique and temperature management on CPB are identical to those
described for total aortic arch replacement. The proximal anastomosis is per-
formed with the aorta crossclamped. Once the anastomosis is completed and
all arrest criteria are fulfilled (temperature 12C–15C, jugular venous
oxygen saturation>94%, and a minimal cooling time of 45 minutes), cir-
culatory arrest is commenced for suturing of the distal anastomosis. Once
completed, total body circulation is resumed and the patient is rewarmed.
No SCP is required for this technique.
DHCA
The technique of DHCA used at our institution was constant throughout
the study and has been described in detail previously. A minimum of 45
minutes of cooling was allowed before arresting the circulation. Adequate
cerebral cooling was ensured in all cases by a jugular venous saturation
of greater than 94% and a nasopharyngeal temperature of 12C to 15C.
In all patients in whom more than 20 minutes of DHCA was anticipated
or SCP was used, the head was packed circumferentially in ice.
Perfusion warming was carried out at the end of the procedure, with the
gradient between the esophageal and blood temperatures maintained at less
than 10C. Warming was maintained until the esophageal temperature
reached 35C and the bladder temperature was greater than 32C. Warming
was usually accomplished in 1 hour of perfusion.
Perfusion
Once on CPB, flow rates of 2.0 to 2.6 L $ min1 $ m2 were maintained,
adjusted to the overall metabolic demand of the individual patient. Lactate
and mixed venous oxygenation were serially followed. Myocardial protec-
tion was provided with cold antegrade blood cardioplegia. In patients with
severe coronary disease, retrograde blood cardioplegia was added. Cardio-
plegic solution was administered every 20 to 30 minutes during periods of
myocardial ischemia. Temperature management of the patient was directed
by the attending surgeon. All cooling was performed with alpha-stat man-
agement. CPB circuits were equipped with a 40-mm arterial line filter,
a non–surface modified membrane oxygenator, and an integrated venous
and cardiotomy reservoir, having a prime volume of 1600 mL. The prime
consisted of PlasmaLyte solution (Baxter Healthcare Corporation, Deer-
field, Ill), 50 mEq NaHCO3, 12.5 g mannitol, and 10,000 U of unfractio-
nated heparin.ery c March 2011
SctO 2  < 50% 
(n = 5) 
SAO (n = 5) 100%   
Delirium 
Renal failure 
Respiratory failure x 3  
Death x 2 
New onset myo cardial     
dysfunction 
Died (n = 2)  
SctO 2  < 55% 
(n = 11) 




Respira tory failure x 2 
New onset myocardial  
dysfunction 
Severe volume overload 
Death 
Died (n = 3)  
SctO 2  < 60%
(n = 15) 





Respiratory failure x 2 
Renal failure x 2 
Sepsis 
Died (n = 3)  
SctO 2  < 65% 
(n = 20) 
SAO (n = 13) 65%   
Respiratory failure 
Renal failure  
Sepsis 
Died (n = 3)  
SctO 2   65%
(n = 10) 
SAO (n = 3)  30%   


































Subjects Assessed for  
eligibility (n = 31) 
Excluded (n = 1) 
Incomplete SAO documentation 







FIGURE 1. CONSORT diagram of 31 patients undergoing elective thoracic aortic surgery with deep hypothermic circulatory arrest (DHCA). SAO, Severe
adverse outcome; SctO2, cerebral tissue oxygen saturation.
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For 2 group comparisons, Fisher’s exact tests were used for categorical
variables and either the Student t tests or nonparametric Wilcoxon tests for
continuous variables, as appropriate. Age-adjusted logistic regression was
used to assess the association between exposure time and severe adverseFIGURE 2. Area under the threshold (AUT). AUT (present)¼ AUT (past)þ
(SctO2 ThresholdSctO2 value) 3 sample rate. SctO2, Cerebral tissue oxy-
gen saturation.




Soutcome (SAO), which was defined as having at least 1 major complication
after surgery. Effects of exposure time are expressed in terms of odds ratios.
Because of the small sample size, profile-likelihood confidence intervals
were used. The c-statistic, also known as the area under the receiver operat-
ing characteristic curve, was also reported to indicate the predictability of
obtaining a SAO, using age and exposure time as predictors. Owing to
the limited number of SAOs, no other covariates were considered in the
model. Spearman correlation coefficients were used to evaluate the strength
of associations between exposure time and area under the SctO2 threshold
for extubation, ICU time, and total hospital LOS time. We performed sen-
sitivity analyses to assess how deaths affect the associations between hospi-
tal outcomes and SctO2. The assumption here is that hospital LOS would
have been longer than the observed if death did not occur. The first analysis
assigned the maximum LOS in the study (¼102 days) to the extubation/
ICU/hospital LOS days for all 3 deaths. The second analysis assigned the
median hospital LOS for the SAO group (¼13 days) to the extubation/
ICU/hospital LOS days for the 1 patient who died before day 13. The last
analysis was based on the original data. All statistical analyses were carried
out using SAS (SAS Institute, Inc, Cary NC). The authors had full access to
the data.RESULTS
Complete postoperative data were available for 30 pa-
tients. One patient was excluded from the study owing to in-
sufficient postoperative documentation. The demographicsrdiovascular Surgery c Volume 141, Number 3 817
TABLE 1. Population demographics and intraoperative and
postoperative data
Variable Mean (SD) or median (IQR)
Weight (kg) 86.0 (23.5)
Height (cm) 176.4 (9.1)
Body surface area (m2) 2.0 (0.3)
Age (y) 68.7 (12.1)
Male (%) 73%
White (%) 83%
Prearrest hematocrit (%) 26.2 (4.2)
Temperature at arrest (C) 13.6 (1.9)
DHCA (min) 24.7 (8.0)
pH 7.4 (0.1)
PaCO2 (mm Hg) 43.2 (6.9)
PaO2 (mm Hg)* 318.5 (264.0, 379.0)
Extubation time (d)* 1.5 (1, 4.0)
ICU stay (d)* 4.0 (3.0, 8.0)
Length of stay (d)* 10.0 (7.0, 14.0)
SD, Standard deviation; IQR, interquartile range, which is the range between 25th and
75th percentiles; DHCA, deep hypothermic circulatory arrest; ICU, intensive care unit.
*Median and IQR were presented when data were not normally distributed.
FIGURE 3. Temporal pattern of SctO2 values during the perioperative
course. Summary box plot is based on the median, quartiles, and extreme
SctO2 values. The box represents the interquartile range, which contains
50% of SctO2 values. The whiskers are lines that extend from the box to
the highest and lowest SctO2 values, excluding outliers. A line across the
box indicates the median. The SctO2 values reported in the box plot are
the mean of left and right forehead cerebral oximetry sensor values. Key
to events: Post Induction, SctO2 right after sensors placed on head during
post induction; Pre CPB, SctO2 2 minutes before onset of CPB; Temp20C,
SctO2 plateau for those subjects with initial hypothermia to 20
C; DHCA
Onset, maximum SctO2 value during deep hypothermia just before DHCA
onset; DHCAþ5 min, SctO2 5 minutes after onset of DHCA; DHCAþ10
min, SctO2 10 minutes after onset of DHCA; DHCAþ15 min, SctO2 15 min-
utes after onset of DHCA; DHCAþ20 min, SctO2 20 minutes after onset of
DHCA; DHCAþ25 min, SctO2 25 minutes after onset of DHCA; DHCAþ30
min, SctO2 30 minutes after onset of DHCA; DHCAþ35 min, SctO2 35 min-
utes after onset of DHCA; End DHCAþ15 min, SctO2 15 minutes after
DHCA; Chest Closed, SctO2 right after end of surgery. N is the number of
subjects out of 30 that had each of the events; SctO2, Cerebral tissue oxygen
saturation.




Sand intraoperative and postoperative information for the 30
patients are displayed in Table 1. Twenty subjects under-
went replacement of the ascending aorta including hemiarch
replacement, and 10 subjects received total aortic arch re-
placements. Figure 3 demonstrates the entire perioperative
course of SctO2. Only 21 patients had a plateau temperature
at 20C before cooling to arrest temperature. The other 9
patients were cooled directly to arrest temperature. Among
the 30 patients, 30 major and 29 minor complications were
identified (Table 2). Sixteen (53.3%) patients had at least
1 major complication, 8 (26.6%) had at least 1 minor com-
plication, and 6 (20%) had no complications reported. For
the purpose of analysis, we defined a SAO as having 1 or
more major postoperative complications. No statistically
significant differences were found between those with and
without a SAO for age, gender, height, prearrest hematocrit,
temperature at the time of DHCA, pH, and PaCO2. Patients
having a SAO weighed less (mean  SD, 77.8  17.0 kg
for SAO vs 95.4  26.8 kg for non-SAO; difference [95%
confidence interval, 17.5 kg (0.3–35.8 kg); P ¼ .047]) and
had a smaller body surface area (1.9  0.2 m2 for SAO vs
2.1  0.3 m2 for non-SAO; difference [95% confidence
interval]: 0.2 (0.0– 0.4) m2; P ¼ 0.046]).
Eight (27%) patients did not have SctO2 values less than
65%. Each of the remaining 22 patients who had an SctO2
of less than 65% also had a decline in SctO2 of less than
60%. Nineteen patients had an SctO2 of less than 55%,
and 12 subjects had an SctO2 of 50%. The integrals of
SctO2 under specific thresholds (AUT) over time are pre-
sented in Table 3. The median exposure times for SctO2
less than 50%, 55%, 60%, and 65% were 4, 12, 29, and
128 minutes, respectively. In addition, among the 19 pa-
tients who had an SctO2 of less than 55%, the median times818 The Journal of Thoracic and Cardiovascular Surgduring which SctO2 fell in the ranges of 60% to 65%, 55%
to 60%, and 50% to 55% were 50, 25, and 9 minutes, re-
spectively. Although only 33% of patients who did not de-
saturate beneath an SctO2 of 65% for more than 10 minutes
had a SAO, this number increased dramatically to 67% for
those subjects who did. All patients with SctO2 values be-
neath 50% for at least 10 minutes had a SAO.
Logistic regression was used to investigate the relation-
ship between SAO and SctO2 exposure time under a given
threshold (TUT), controlling for age (Table 4). There were
statistically significant associations between TUT and
SAO incidence for SctO2 thresholds of 60% (P ¼ .038)
and 65% (P ¼ .025). Figure 4 demonstrates the odds ratios
with 95% confidence intervals for SAO for incremental ex-
posure time to SctO2 values under specific thresholds. For
every 5% decrease in the absolute SctO2 threshold, the incre-
mental exposure time to achieve a given odds ratio (for
SAO) decreased by half for SctO2 thresholds between 55%
and 65%. The predictive values (c-statistic) of TUT forery c March 2011
TABLE 2. Complications
Major complications Subjects with complication
Death 3 (10%)
Stroke 3 (10%)
New-onset myocardial dysfunction 2 (6.7%)
Respiratory failure 8 (26.7%)
Sepsis 3 (10%)
Delirium 4 (13.4%)
Renal failure requiring dialysis 4 (13.4%)
GI complications requiring intervention 1 (3.3%)
Severe volume overload, edema 2 (6.7%)
Minor or no complication
Atrial fibrillation 13 (44.8%)
Minor volume overload 7 (24.1%)
Phlebitis 3 (10.3%)
None 6 (20.7%)
TABLE 4. Logistic regression models for the relationships between







SctO2<55% Intercept 4.898 2.795 .080
TUT (min) 0.061 0.039 .117
Age (y) 0.063 0.038 .098
SctO2<60% Intercept 6.047 3.116 .052
TUT (min) 0.034 0.016 .038
Age(y) 0.074 0.042 .077
SctO2<65% Intercept 5.693 3.045 .063
TUT (min) 0.016 0.007 .025
Age (y) 0.067 0.040 .096
The probability of SAO is Pr (SAO) ¼ expðyÞ1þ expðyÞ,where exp() is the exponential
function, and y is calculated using the ß-coefficients above. For example, for a
70 year-old patient who had 30 minutes of SctO2 under 65%, y ¼5:693þ
0:0163TUTþ0:0673 age ¼5:693þ0:016330þ0:0673 70 ¼ 0:523: Then,
Pr (SAO) ¼ 0.37. SAO, Severe adverse outcome; SctO2, cerebral tissue oxygen
saturation.




SSAO (controlling for age) were 0.77, 0.81, and 0.83 for
SctO2 thresholds of 55, 60, and 65%, respectively. Older
age demonstrated a marginally significant trend toward pre-
dicting SAO (0.05<P<.1 for all 3 threshold models). The
odds of having a SAO roughly doubled for every 10 years
increase in age.
On the basis of these findings, we further explored the re-
lationship between duration of exposure time and AUT and
hospital course. We considered 3 analyses to take into ac-
count deaths in different ways (see Methods section for de-
tails). The assumption is that hospital LOS would have been
longer than that observed if death had not occurred. Overall,
Spearman correlations showed a positive relationship be-
tween time and AUT for extubation time, ICU stay, and hos-
pital LOS (Table 5). In particular, in all 3 analyses, patients
with greater duration of low SctO2 and showing greater inte-
grals of low SctO2 over time for the SctO2 threshold values of
65% and 60% were significantly more likely to have pro-
longed postoperative mechanical ventilation and longer
LOS in the ICU. The hospital LOS demonstrated the same
trend as extubation time and ICU LOS, but lost its signifi-
cance when original data were used. The SctO2 threshold
values of 55% showed slightly lower correlations, as a result
of fewer patients having time points spent below this thresh-
old (thus, a big cluster of zeros for time and AUT).
Finally, we explored the financial burden posed on our in-
stitution as a direct result of prolonged ICU and hospitalTABLE 3. Exposure time and area under SctO2 thresholds
SctO2 (%) N (%)
Median (range)
Time (min) AUT (% - min)
SctO2<50% 12 (40%) 4.0 (0.1, 263.0) 6.7 (0.2, 1973.8)
SctO2<55% 19 (63%) 11.7 (0.2, 363.1) 29.0 (0.1, 3575.4)
SctO2<60% 22 (73%) 28.5 (0.7, 425.0) 117.6 (1.1, 5544.9)
SctO2<65% 22 (73%) 128.1 (2.7, 486.9) 382.9 (14.3, 7829.4)
SctO2, Cerebral tissue oxygen saturation; AUT, area under threshold.
The Journal of Thoracic and CaLOS. For the purpose of illustration, we applied the predic-
tive model to patients who spent more than 30 minutes
beneath the SctO2 threshold value of 60% as opposed to pa-
tients who did not. Median LOS was predicted to be 3 days
longer (6 vs 3) in the ICU, and the total hospital stay was
4 days longer (13 vs 9), of which 2 days were attributable
to ICU stay and 1 to non-ICU stay. The total cost of this
additional stay was calculated to be $8300.00 at our institu-
tion using hospital financial estimates of cardiac surgical
inpatient costs.
DISCUSSION
Decreased SctO2 values were associated with major com-
plications, prolonged postoperative mechanical ventilation,
and prolonged ICU and hospital LOS. Both the nadir of
SctO2 and the integral of low SctO2 over time were associated
with severe adverse outcomes. Each additional decade of life
was associated with doubled risk of SAO.
The current study is not the first to demonstrate associa-
tions among cerebral oximetry values and clinical outcomes
during the perioperative period. Recent work by Murkin
and colleagues3 demonstrated reduced LOS in patients un-
dergoing coronary artery bypass grafting when low SctO2
episodes were treated with a preset protocol. Slater and col-
leagues9 found that patients with prolonged low SctO2 un-
dergoing coronary artery bypass grafting had a higher
incidence of early postoperative neurocognitive dysfunction
and prolonged hospital LOS. Casati and colleagues10
showed a shorter length of postanesthesia care unit and hos-
pital LOS in abdominal surgery when patients were actively
treated to maintain SctO2 greater than 75% of the baseline
values using a preset algorithm. Previous studies have
also identified the geriatric age group as an independent
risk factor for early mortality in complex cardiacrdiovascular Surgery c Volume 141, Number 3 819
FIGURE 4. Odds ratios for SAO for incremental exposure time to SctO2
values under specific thresholds. For every 5% decrease in the absolute
SctO2 threshold, the incremental exposure time to achieve a given odds ratio
(for SAO) decreased by half for SctO2 thresholds between 55% and 65%.
C-statistics of time under the threshold for SAO were 0.77, 0.81 and 0.83
and for SctO2 thresholds of 55, 60, and 65%, respectively. The odds of hav-
ing a SAO roughly doubled for every 10 years’ increase in age. SAO, Severe
adverse outcome; SctO2, cerebral tissue oxygen saturation.
TABLE 5. Spearman correlation coefficients (rs) for SctO2 thresholds
and postoperative hospital outcomes
SctO2 (%)
Extubation time ICU stay Hospital LOS
rs
P
value rs P value rs
P
value
<65% (min) 0.53*,1 .002 0.58* <.001 0.49* .006
0.53*,1 .002 0.57* <.001 0.41* .024
0.51*,1 .004 0.51* .004 0.27 .149
<60% (min) 0.48* .008 0.50* .005 0.44* .015
0.47* .008 0.49* .006 0.37* .046
0.45* .013 0.42* .020 0.23 .222
<55% (min) 0.35y .057 0.43* .019 0.40* .027
0.35y .059 0.42* .022 0.34y .070
0.32y .084 0.34y .065 0.20 .300
<65% AUT (%-min) 0.50* .005 0.52* .003 0.45* .013
0.50* .005 0.51* .004 0.38* .041
0.47* .008 0.44* .015 0.24 .207
<60% AUT (%-min) 0.41* .024 0.46* .010 0.39* .034
0.41* .024 0.45* .013 0.31y .091
0.38* .037 0.38* .040 0.18 .346
<55% AUT (%-min) 0.35y .058 0.42* .020 0.39* .031
0.35y .060 0.41* .024 0.32y .090
0.32y .085 0.34y .069 0.17 .350
SctO2, Cerebral tissue oxygen saturation; ICU, intensive care unit; LOS, length of stay;
AUT, area under threshold; SAO, severe adverse outcome. *P value < .05 yP
value<0.1 (2-tailed). 1The study had 3 patients who died; all had SAO and died in
the ICU while extubated. Their hospital LOSs were 4, 13 and 102 days, respectively.
We performed sensitivity analyses to assess how deaths affect the associations be-
tween hospital outcomes and SctO2. The assumption here is that hospital LOS would
have been longer than the observed if death did not occur. The first row of the spear-
man correlations were calculated by assigning 102 days (maximum LOS in the study)
to the exbubation/ICU/hospital LOS days for all 3 deaths. In the second row the Spear-
man correlations were calculated by assigning 13 days (median hospital LOS for the
SAO group) to the exbubation/ICU/hospital LOS days for the patient who died on day
4. In the last row the correlations were based on the original data.




Ssurgery.11,12 This is consistent with the general finding
that advanced age is associated with loss of end-organ
reserve.13
This was a prospective observational study. Although sta-
tistically significant associations were present, it is unknown
whether interventions to increase SctO2 would have averted
adverse outcomes. Additionally, perioperative management
changes over time. One example in the current study is that
aprotinin was withdrawn from clinical practice during pa-
tient enrollment, and the small number of patients does not
permit analysis of this variable. This study enrolled only pa-
tients presenting for aortic arch surgery, and SctO2 was mon-
itored only during the intraoperative period.
The Brain as a Sentinel Organ
The current study and the ones cited herein demonstrate
an evolution in the interpretation of SctO2 data. Although820 The Journal of Thoracic and Cardiovascular Surginvestigators were focused originally on the brain and cere-
bral outcomes, the emerging hypothesis is that SctO2 mon-
itoring may be an index of overall organ perfusion and
injury. Our finding that a statistically significant model
using SctO2 data predicted ICU and hospital LOS under-
scores this point and suggests that future studies may inves-
tigate the cost-effectiveness of this form of monitoring and
intervention.
It is too early to recommend specific target SctO2 values
that should be maintained in different clinical settings. On
a very preliminary basis, using the technology in this study
in the clinical setting of thoracic aortic surgery, we believe
that an SctO2 of 60% to 65% could represent this threshold
value.
In summary, the current study lends further evidence to
support the association of decreased perioperative cerebral
oxygenation values with poor outcomes. The preliminary
finding that absolute threshold values are predictive of ad-
verse outcomes suggests that future investigations should
follow the Murkin model of prospective interventional trials
that assess general perioperative outcomes.ery c March 2011
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